News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,554 Results
Type
Article (88701)
Company Profile (816)
Press Release (793014)
Multimedia
Podcasts (234)
Webinars (35)
Section
Business (233554)
Career Advice (4161)
Deals (39967)
Drug Delivery (176)
Drug Development (91667)
Employer Resources (207)
FDA (18546)
Job Trends (17480)
News (398650)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3050)
Academic (2)
Accelerated approval (54)
Adcomms (40)
Allergies (189)
Alliances (56988)
ALS (228)
Alzheimer's disease (1956)
Antibody-drug conjugate (ADC) (533)
Approvals (18862)
Artificial intelligence (842)
Autoimmune disease (342)
Automation (62)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (210)
Brain cancer (84)
Breast cancer (822)
Cancer (6416)
Cardiovascular disease (546)
Career advice (3595)
Career pathing (51)
CAR-T (371)
CDC (76)
Celiac Disease (3)
Cell therapy (1045)
Cervical cancer (51)
Clinical research (78743)
Collaboration (2312)
Company closure (8)
Compensation (1466)
Complete response letters (103)
COVID-19 (3037)
CRISPR (121)
C-suite (1248)
Cystic fibrosis (166)
Data (8426)
Decentralized trials (3)
Denatured (89)
Depression (190)
Dermatology (94)
Diabetes (651)
Diagnostics (7557)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (414)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (311)
Earnings (102461)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138239)
Executive appointments (1178)
FDA (22524)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1891)
Gene editing (267)
Generative AI (87)
Gene therapy (841)
GLP-1 (1260)
Government (5553)
Grass and pollen (8)
Guidances (417)
Healthcare (21207)
HIV (91)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (107)
Immunology and inflammation (351)
Immuno-oncology (111)
Indications (199)
Infectious disease (3427)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (309)
Interviews (820)
IPO (17996)
IRA (61)
Job creations (5206)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (117)
Layoffs (683)
Leadership (52)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (853)
Lymphoma (451)
Machine learning (65)
Management (66)
Manufacturing (1186)
MASH (220)
Medical device (15255)
Medtech (15394)
Mergers & acquisitions (23251)
Metabolic disorders (1744)
mRNA (258)
Multiple sclerosis (202)
NASH (24)
Neurodegenerative disease (490)
Neuropsychiatric disorders (126)
Neuroscience (3654)
Neurotech (2)
NextGen: Class of 2026 (7714)
Non-profit (5140)
Now hiring (80)
Obesity (838)
Opinion (371)
Ovarian cancer (239)
Pain (281)
Pancreatic cancer (330)
Parkinson's disease (405)
Partnered (39)
Patents (640)
Patient recruitment (727)
Peanut (67)
People (67878)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24335)
Phase 2 (34201)
Phase 3 (25722)
Pipeline (9383)
Policy (394)
Postmarket research (3559)
Preclinical (10949)
Press Release (72)
Prostate cancer (337)
Psychedelics (68)
Radiopharmaceuticals (366)
Rare diseases (1227)
Real estate (7461)
Recruiting (81)
Regulatory (30250)
Reports (77)
Research institute (2767)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (194)
Series A (318)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4368)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (104)
The Weekly (142)
Vaccines (1290)
Venture capital (128)
Weight loss (577)
Women's health (136)
Worklife (24)
Date
Today (84)
Last 7 days (694)
Last 30 days (3383)
Last 365 days (32983)
2026 (14913)
2025 (33222)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (395)
Arkansas (16)
Asia (52206)
Australia (9179)
California (14128)
Canada (3960)
China (1519)
Colorado (605)
Connecticut (627)
Delaware (434)
Europe (120361)
Florida (2094)
Georgia (461)
Hawaii (4)
Idaho (70)
Illinois (1216)
India (101)
Indiana (654)
Iowa (25)
Japan (575)
Kansas (142)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1720)
Massachusetts (10308)
Michigan (421)
Minnesota (786)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3744)
New Mexico (34)
New York (3707)
North Carolina (1910)
North Dakota (11)
Northern California (7013)
Ohio (438)
Oklahoma (26)
Oregon (55)
Pennsylvania (2798)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5527)
Tennessee (223)
Texas (2292)
United States (50534)
Utah (422)
Vermont (1)
Virginia (357)
Washington D.C. (89)
Washington State (1163)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 882,554 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
June 1, 2026
·
5 min read
Press Releases
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC
June 1, 2026
·
10 min read
Press Releases
Long-term Follow-up Results of CARsgen’s Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting
June 1, 2026
·
5 min read
Press Releases
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept
June 1, 2026
·
12 min read
Press Releases
BriaCell Therapeutics Announces Pricing of Offering
June 1, 2026
·
3 min read
Press Releases
TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First-Line R/M HNSCC at ASCO 2026
June 1, 2026
·
5 min read
Press Releases
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
June 1, 2026
·
10 min read
Press Releases
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
June 1, 2026
·
9 min read
Press Releases
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
June 1, 2026
·
9 min read
Press Releases
Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026
June 1, 2026
·
13 min read
1 of 88,256
Next
